New cancer drug shows promise in early trial for Hard-to-Treat tumors
Disease control
Recruiting now
This study tests a new drug called SPR1020 in people with advanced solid tumors that have not responded to other treatments. The drug is designed to target cancer cells with specific genetic changes while causing fewer side effects than older similar drugs. The trial will first f…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai SciBrunch Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC